DOLIPRANE Side Effects

7018318-5 | Cytolytic Hepatitis, Renal Failure Acute, Rhabdomyolysis
on Sep 15, 2010 Female patient from FRANCE , 80 years of age, was diagnosed with hyperthermia and was treated with Doliprane (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, renal failure acute, rhabdomyolysis. Doliprane dosage: 4 Tablets On 07-aug-2010 And 3 Tablets On 08-aug-2010. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), TAHOR (View Tahor Review and Tahor Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PREVISCAN (View Previscan Review and Previscan Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SERESTA (View Seresta Review and Seresta Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6566337-5 | Cytolytic Hepatitis, Jaundice
Patient was taking Doliprane (View Usage). Patient had the following side effects: cytolytic hepatitis, jaundice (What is jaundice?) on Jan 27, 2010 from FRANCE Additional patient health information: Male patient , 56 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and. Doliprane dosage: Dose:4 Unit(s). During the same period patient was treated with LOVENOX (Dose:1 Unit(s)) (View Lovenox Review and Lovenox Label ), TAVANIC (Dose:2 Unit(s)) (View Tavanic Review and Tavanic Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), MOXIFLOXACIN HCL (Dose:1 Unit(s)) (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), ZECLAR (Dose:2 Unit(s)) (View Zeclar Review and Zeclar Label ), PERFALGAN (Dose:4 Unit(s)) (View Perfalgan Review and Perfalgan Label ), CIPROFLOXACIN HCL (Dose:3 Unit(s)) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), TAZOCILLINE (Dose:4 Unit(s)) (View Tazocilline Review and Tazocilline Label ). Patient was hospitalized.

5942146-2 | Altered State Of Consciousness, Bronchial Oedema, Convulsion, Encephalopathy, Epilepsy
Adverse event was reported on Oct 30, 2008 by a Female patient taking Doliprane (View Usage) (Dosage: ) . Location: , 70 years of age, After Doliprane was administered, patient had the following side effects: altered state of consciousness, bronchial oedema, convulsion, encephalopathy, epilepsy (What is epilepsy?). During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), AXEPIM (View Axepim Review and Axepim Label ), PROZAC (View Prozac Review and Prozac Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), SKENAN (View Skenan Review and Skenan Label ), FORLAX (View Forlax Review and Forlax Label ), MOPRAL (View Mopral Review and Mopral Label ).

5921913-5 | Altered State Of Consciousness, Bronchial Oedema, Cerebral Atrophy, Convulsion, Encephalopathy, Epilepsy, Hypotonia, Overdose
on Oct 07, 2008 Female patient from , 70 years of age, was treated with Doliprane (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, bronchial oedema, cerebral atrophy, convulsion, encephalopathy, epilepsy (What is epilepsy?), hypotonia, overdose. Doliprane dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), AXEPIM (View Axepim Review and Axepim Label ), PROZAC (View Prozac Review and Prozac Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), SKENAN (View Skenan Review and Skenan Label ), FORLAX (View Forlax Review and Forlax Label ), MOPRAL (View Mopral Review and Mopral Label ).


5601613-1 | Asthenia, Confusional State, Dehydration, Renal Failure Acute
on Jan 14, 2008 Male patient from FRANCE , 75 years of age, weighting 190.7 lb, was diagnosed with pain (What is pain?), hypertension, neuralgia, insomnia and was treated with Doliprane (View Usage). Patient had the following side effects: asthenia, confusional state, dehydration, renal failure acute. Doliprane dosage: . During the same period patient was treated with AMLOR (View Amlor Review and Amlor Label ), ATACAND (View Atacand Review and Atacand Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), LAROXYL (View Laroxyl Review and Laroxyl Label ), ANAFRANIL (View Anafranil Review and Anafranil Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

5168927-3 | International Normalised Ratio Increased, Prothrombin Level Decreased
Patient was taking Doliprane (View Usage). After Doliprane was administered, patient had the following side effects: international normalised ratio increased, prothrombin level decreased on Dec 04, 2006 from Additional patient health information: Male patient , 84 years of age, . Doliprane dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ), LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), RENITEC /00574901/ (View Renitec /00574901/ Review and Renitec /00574901/ Label ), FORLAX (View Forlax Review and Forlax Label ), HYPERIUM /00939801/ (View Hyperium /00939801/ Review and Hyperium /00939801/ Label ). Patient was hospitalized.

5083663-X | Coma, Condition Aggravated, Dehydration, Diabetes Mellitus, Hyperglycaemia, Hypernatraemia
Adverse event was reported on Aug 09, 2006 by a Male patient taking Doliprane (View Usage) (Dosage: Unk) was diagnosed with essential hypertension and. Location: FRANCE , 92 years of age, Patient experienced the following unwanted or unexpected effects: coma, condition aggravated, dehydration, diabetes mellitus, hyperglycaemia, hypernatraemia. During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), DIFFU K (Unk) (View Diffu K Review and Diffu K Label ), STILNOX (Unk) (View Stilnox Review and Stilnox Label ), DEPAKENE (Unk) (View Depakene Review and Depakene Label ), CORDARONE (Unk) (View Cordarone Review and Cordarone Label ). Patient was hospitalized.

4968726-9 | Bone Disorder, Gingivitis, Impaired Healing, Tooth Extraction
on Jul 07, 2005 Female patient from FRANCE , 59 years of age, weighting 169.8 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Doliprane (View Usage). Patient had the following side effects: bone disorder, gingivitis, impaired healing, tooth extraction. Doliprane dosage: . During the same period patient was treated with CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), FEMARA (2.5 Mg, Qd) (View Femara Review and Femara Label ), ZOLEDRONIC ACID (4mg) (View Zoledronic Acid Review and Zoledronic Acid Label ).

4964465-9 | Abdominal Pain, Cytolytic Hepatitis
on Mar 30, 2006 Male patient from , 39 years of age, weighting 198.4 lb, was diagnosed with nasopharyngitis and was treated with Doliprane (View Usage). After Doliprane was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cytolytic hepatitis. Doliprane dosage: . During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

4917167-9 | Agranulocytosis, Cytolytic Hepatitis, Hyperthermia, Neutropenia, Rash Vesicular, Staphylococcal Infection
Patient was taking Doliprane (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, cytolytic hepatitis, hyperthermia, neutropenia, rash vesicular, staphylococcal infection (What is staphylococcal infection?) on Feb 09, 2006 from Additional patient health information: Male patient , 23 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Doliprane dosage: . During the same period patient was treated with GARDENALE (View Gardenale Review and Gardenale Label ), LOVENOX (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

4772987-9 | Anuria, Cough, Leukopenia, Lung Disorder, Multi-organ Failure, Pneumonia Legionella, Renal Failure Acute, Septic Shock, Tachypnoea
Adverse event was reported on Sep 15, 2005 by a Male patient taking Doliprane (View Usage) (Dosage: Unk, Unk) was diagnosed with chest pain (What is chest pain?), lung disorder and. Location: FRANCE , 51 years of age, weighting 176.4 lb, Patient had the following side effects: anuria, cough, leukopenia, lung disorder, multi-organ failure, pneumonia legionella, renal failure acute, septic shock, tachypnoea. During the same period patient was treated with TAREG (View Tareg Review and Tareg Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BI PROFENID (View Bi-profenid Review and Bi-profenid Label ). Patient was hospitalized.

4731439-2 | Anuria, Cardiovascular Deconditioning, Depressed Level Of Consciousness, Hypoglycaemia, Multi-organ Failure, Necrotising Fasciitis, Renal Failure, Respiratory Failure, Septic Shock
on Jul 28, 2005 Male patient from , 62 years of age, weighting 264.6 lb, was diagnosed with myalgia, myositis (What is myositis?), diabetes mellitus non-insulin-dependent, essential hypertension, pancreatic disorder, gastric ulcer and was treated with Doliprane (View Usage). After Doliprane was administered, patient had the following side effects: anuria, cardiovascular deconditioning, depressed level of consciousness, hypoglycaemia, multi-organ failure, necrotising fasciitis, renal failure, respiratory failure, septic shock. Doliprane dosage: . During the same period patient was treated with AMAREL (View Amarel Review and Amarel Label ), TRANDATE (View Trandate Review and Trandate Label ), CREON (View Creon Review and Creon Label ), MOPRAL (View Mopral Review and Mopral Label ), UPFEN (View Upfen Review and Upfen Label ). Patient was hospitalized.

4705119-3 | Dyspnoea, International Normalised Ratio Increased, Prothrombin Level Decreased
on Jun 20, 2005 Male patient from , 84 years of age, was treated with Doliprane (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, international normalised ratio increased, prothrombin level decreased. Doliprane dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), PREVISCAN (View Previscan Review and Previscan Label ), OMIX (View Omix Review and Omix Label ), NOVONORM (View Novonorm Review and Novonorm Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

4613751-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytolytic Hepatitis, Epstein-barr Virus Antibody Positive, Hepatic Necrosis, Nephropathy Toxic, Renal Failure
Patient was taking Doliprane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cytolytic hepatitis, epstein-barr virus antibody positive, hepatic necrosis, nephropathy toxic, renal failure on Mar 14, 2005 from Additional patient health information: Female patient , 24 years of age, weighting 112.4 lb, was diagnosed with renal transplant and. Doliprane dosage: . During the same period patient was treated with NEORAL (125 Mg, Bid) (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

4585829-1 | Cholestasis, Conjunctivitis, Cytolytic Hepatitis, Fibrin Degradation Products Increased, Haemorrhage, Hepatic Failure, Hypersensitivity
Adverse event was reported on Nov 19, 2004 by a Female patient taking Doliprane (View Usage) (Dosage: ) was diagnosed with sle arthritis, epilepsy (What is epilepsy?) and. Location: , 41 years of age, After Doliprane was administered, patient had the following side effects: cholestasis, conjunctivitis, cytolytic hepatitis, fibrin degradation products increased, haemorrhage, hepatic failure, hypersensitivity. During the same period patient was treated with CACIT D3 (View Cacit D3 Review and Cacit D3 Label ), PLAQUENIL (400 Mg) (View Plaquenil Review and Plaquenil Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), LAMICTAL (50 Mg) (View Lamictal Review and Lamictal Label ). Patient was hospitalized and became disabled.